NPI: 1609842749 · LAWRENCE, NY 11559 · 207W00000X
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 4,043 | $169K |
| 2019 | 5,190 | $210K |
| 2020 | 5,946 | $257K |
| 2021 | 8,680 | $347K |
| 2022 | 9,779 | $424K |
| 2023 | 11,789 | $598K |
| 2024 | 8,220 | $366K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 92014 | 10,221 | 10,100 | $632K | |
| 92012 | 4,789 | 4,358 | $195K | |
| 92083 | 4,582 | 4,546 | $188K | |
| 92250 | 6,760 | 6,623 | $176K | |
| 92273 | 2,700 | 2,635 | $176K | |
| 67028 | 2,676 | 2,171 | $145K | |
| 92235 | 2,433 | 2,305 | $138K | |
| 68761 | 1,511 | 836 | $109K | |
| J0178 | Aflibercept injection | 279 | 205 | $108K |
| 92004 | 1,164 | 1,150 | $94K | |
| 99204 | 837 | 824 | $73K | |
| 92020 | 4,582 | 4,515 | $67K | |
| J9035 | Bevacizumab injection | 929 | 755 | $45K |
| 92134 | 2,982 | 2,714 | $41K | |
| 92133 | 1,621 | 1,609 | $37K | |
| J2777 | Inj, faricimab-svoa, 0.1mg | 78 | 53 | $37K |
| 67228 | 138 | 123 | $29K | |
| 76512 | 803 | 600 | $24K | |
| 92226 | 1,253 | 937 | $16K | |
| J2778 | Ranibizumab injection | 32 | 24 | $13K |
| 92015 | 846 | 838 | $12K | |
| 92202 | 1,567 | 1,488 | $10K | |
| 92287 | 21 | 21 | $2K | |
| 68801 | 60 | 24 | $2K | |
| 76514 | 190 | 187 | $1K | |
| 92132 | 68 | 66 | $1K | |
| 92225 | 16 | 13 | $245.88 | |
| G8427 | Docrev cur meds by elig clin | 192 | 156 | $0.00 |
| G9903 | Pt scrn tbco id as non user | 317 | 274 | $0.00 |